BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Xigen S.A., Swiss Developer of Therapeutic Peptides, Raises $20 Million in Series B Funding

  November 20, 2009

   · 

  1 min read
• Deals

  Procter & Gamble Repurchasing Shares, Quiet on Potential Deals

  November 20, 2009

   · 

  1 min read
• Drug Development

  Circassia Limited Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy Study Identifies Optimal Treatment Approach for Late-Stage Development

  November 20, 2009

   · 

  3 min read
• Drug Development

  Genta Incorporated’s Genasense(R) Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma

  November 20, 2009

   · 

  1 min read
• BioMidwest

  Company Profile for PreventionGenetics LLC

  November 20, 2009

   · 

  1 min read
• Business

  ImmunoGen, Inc. Licenses Anti-Cancer Technology to Amgen (JOBS); ImmunoGen to Get Up to $34 Million in Milestone Payments

  November 20, 2009

   · 

  1 min read
• Policy

  FDA Panel Rejects Protein Sciences Corporation’s Cell Culture Flu Vaccine, Wants More Safety Data

  November 20, 2009

   · 

  1 min read
• Policy

  Cell Therapeutics, Inc. Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group

  November 20, 2009

   · 

  2 min read
• FDA

  FDA Approves Intravenous Formulation Of Pfizer Inc.'s (JOBS) Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

  November 20, 2009

   · 

  5 min read
• Deals

  ONI Medical Systems, Inc. Successfully Closes MRI Technology Platform Sale to GE Healthcare

  November 20, 2009

   · 

  2 min read